SLC1A6 and Parkinson disease: For instance, miR-128 stands as a potential target for PD therapeutics since its expression affects apoptotic mechanisms in DA neurons along with the expression of excitatory amino acid transporter 4 (EAAT4) [132], which are high-affinity glutamate transporters.